Rudrapur Mri & Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-12-2024
- Paid Up Capital ₹ 1.15 M
as on 17-12-2024
- Company Age 16 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.16 Cr
as on 17-12-2024
- Revenue -20.36%
(FY 2023)
- Profit -13.07%
(FY 2023)
- Ebitda -13.96%
(FY 2023)
- Net Worth 22.50%
(FY 2023)
- Total Assets -1.89%
(FY 2023)
About Rudrapur Mri & Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.15 M.
The company has closed loans amounting to ₹3.16 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anand Rungta and Pradeep Kumar serve as directors at the Company.
- CIN/LLPIN
U85100UR2008PTC032739
- Company No.
032739
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Udham Singh Nagar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rudrapur Mri & Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Rungta  | Director | 19-Dec-2008 | Current |
| Pradeep Kumar | Director | 19-Dec-2008 | Current |
Financial Performance of Rudrapur Mri & Diagnostics.
Rudrapur Mri & Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.36% decrease. The company also saw a substantial fall in profitability, with a 13.07% decrease in profit. The company's net worth Soared by an impressive increase of 22.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rudrapur Mri & Diagnostics?
Unlock access to Rudrapur Mri & Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Jun 2020 | ₹7.50 M | Satisfied |
The Nainital Bank Limited Creation Date: 02 Nov 2015 | ₹2.10 M | Satisfied |
The Nainital Bank Limited Creation Date: 13 Nov 2014 | ₹1.20 Cr | Satisfied |
How Many Employees Work at Rudrapur Mri & Diagnostics?
Unlock and access historical data on people associated with Rudrapur Mri & Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rudrapur Mri & Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rudrapur Mri & Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
